19 reports

Generic Drugs Market

4297 4900 3822

Generic Drugs Market Research Report: By Type (Simple, Super, Biosimilars), Application (Neurological Diseases, Cardiological Diseases, Metabolic Diseases, Infectious Diseases, Orthopedic Diseases, Genitourinary/Hormonal Diseases, Respiratory Diseases), Route of Administration (Oral, Injection, Cutaneous, Mucosal, Inhalation), Distribution...

  • Generic Drug
  • World

Report Scope This report discusses the implications of all the above-mentioned trends in the context of the current size and growth of the market for generic drugs, both in global terms and broken down by the most important national markets.The nature and structure of the generic drug industry is discussed, with profiles...

  • Generic Drug
  • World

Major players in the generic pharmaceuticals market are Teva Pharmaceuticals, Mylan NV, Sandoz International GmbH, Hospira (Pfizer Inc.), Sun Pharmaceutical, Lupin Limited, Endo International Plc., Dr Reddy’s Laboratories, Apotex Holdings, Fresenius Kabi Ag, Aurbindo Pharma, Aspen Pharmacare, Sanofi, Cipla, Hikma Pharmaceuticals, Stada Arzneimittel,...

  • Generic Drug
  • World
  • United States
  • Middle East
  • APAC
  • Health Provider Density
  • Cause-Specific Mortality Rate

Global Generic Drugs Market 2021-2025 The analyst has been monitoring the generic drugs market and it is poised to grow by $ 138.90 bn during 2021-2025, progressing at a CAGR of 6.33% during the forecast period. Our report on the generic drugs market provides a holistic analysis, market size and forecast, trends, growth...

  • Generic Drug
  • World

Global Generic Drugs Market, By Type (Small Molecule Generics vs Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others), By Drug Delivery (Oral, Topical, Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House vs Contract Manufacturing...

  • Generic Drug
  • World
  • Chronic Disease Prevalence
  • Diabetes Prevalence

Generic injectables are bio-equivalents of their branded counterparts which are not protected by drug patents. They are as safe and effective as the innovator drugs since they have similar active ingredient, dosage, strength, quality, form, etc. Although the manufacturing of generic injectables is complex, their R&D...

  • Research And Development
  • Generic Drug
  • Anti-Infective
  • Parenteral Nutrition
  • In-Store Retail
  • Chronic Disease
  • Pharmacy
  • Cardiology
  • World

Generic Drugs Market Report 2020-2030: Growth in Leading Regional and National Markets (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America, US, Canada, Germany, France, UK, Italy, Spain, India, China, Australia, South Korea, Japan, South Africa, Saudi Arabia, U.A.E, Brazil, Argentina, Mexico, Teva, Novartis, Mylan,...

  • Generic Drug
  • World
  • APAC
  • Health Expenditure
  • Generics Use

Biotech Ingredients Market by Type (Active Pharmaceutical Ingredients and Biosimilars), Product (Monoclonal Antibodies, Vaccines, Hormones and Growth Factors, Cytokines, Fusion Proteins, Therapeutic Enzymes, and Blood Factors), and Expression Systems (Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems,...

  • Biotechnology
  • Generic Drug
  • World
  • Generics Use

Global Eye Infections Therapeutics Market: About this market This eye infections therapeutics market analysis considers sales from conjunctivitis, keratitis, blepharitis, and other eye infections types. Our analysis also considers the sales of eye infections therapeutics in Asia, Europe, North America, and ROW. In...

  • Therapy
  • Generic Drug
  • World
  • Generic Drugs Market Share
  • Health Expenditure

Generics in Brazil - Market Summary, Competitive Analysis and Forecast to 2025 Summary Generics in Brazil industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2016-20, and forecast to 2025). The profile also contains...

  • Pharmaceutical
  • Generic Drug
  • Brazil
  • Generics Use
  • Consumer Price Index

Generics in Turkey - Market Summary, Competitive Analysis and Forecast to 2025 Summary Generics in Turkey industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the...

  • Pharmaceutical
  • Generic Drug
  • Medical Device
  • Turkey
  • Consumer Price Index
  • Generic Drugs Market Share

This study covers the world outlook for cold-chain generic drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Cold Chain
  • Generic Drug
  • World
  • Gross Domestic Product
  • Disposable Income

Generics in Spain Summary Generics in Spain industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and...

  • Pharmaceutical
  • Generic Drug
  • Spain
  • Consumer Price Index
  • Generics Use

This study covers the latent demand outlook for cold-chain generic drugs across the states, union territories, and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 4,900 cities in India. For each city in question, the percent share the city is of its...

  • Generic Drug
  • Cold Chain
  • India
  • United States
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for cold-chain generic drugs across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred...

  • Generic Drug
  • Cold Chain
  • China
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for cold-chain generic drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city is...

  • Generic Drug
  • Cold Chain
  • United States
  • Disposable Income
  • Purchasing Power Parity

About Modular Cleanroom A cleanroom is an environmentally controlled enclosure determined by the number of airborne particulates, temperature, air pressure, humidity, airflow patterns and motion, static charges, and lighting. Adhesion of particles is prevented to ensure high-quality, reliable products and operations. The cleanliness...

  • Semiconductor
  • Generic Drug
  • Healthcare
  • Automotive
  • Aerospace And Defense
  • APAC
  • Prescription Drug Sales
  • Drug Approval

In recent times there has been a growing focus on the generic drugs industry worldwide. The patent expiry of leading drugs in recent years and also the upcoming patent expiries has put a focus on the global generics industry. Over the years, the global generic drugs industry has grown strongly owing partly to the fact that the period for patent...

  • Pharmaceutical
  • Generic Drug
  • Drug Development
  • APAC
  • World
  • China
  • Japan
  • India
  • Generics Use
  • Generic Drugs Market Share

A generic drug is a copy that is the same as a brand-name drug in dosage, safety, strength, how it is taken, quality, performance and intended use. Generic drugs are less expensive because generic manufacturers don't have the investment costs of the developer of a new drug. New drugs are developed under patent protection. The...

  • Pharmaceutical
  • Generic Drug
  • United States
  • Drug Approval
  • Health Expenditure